This Article Full Text Full Text (PDF) All Versions of this Article: 21/1/259    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mamin, A. Articles by Philippe, J. Search for Related Content PubMed PubMed Citation Articles by Mamin, A. Articles by Philippe, J.

Activin A Decreases glucagon and arx Gene Expression in -Cell Lines

Diabetes Unit, Division of Endocrinology, Diabetes and Nutrition, University Hospital G, 1211 Geneva 14, Switzerland

Address all correspondence and requests for reprints to: Aline Mamin, Diabetes Unit, Division of Endocrinology, Diabetes and Nutrition, University Hospital Geneva, 24, rue Micheli-du-Crest, CH-1211 Geneva 14, Switzerland. E-mail: aline.mamin{at}medecine.unige.ch.

Activin A is a potent growth and differentiation factor involved in development, differentiation, and physiological functions of the endocrine pancreas; it increases insulin and pax4 gene expression in ß-cells and can induce transdifferentiation of the exocrine acinar cell line AR42J into insulin-producing cells. We show here that Activin A decreases glucagon gene expression in the -cell lines InR1G9 and TC1 in a dose- and time-dependent manner and that the effect is blocked by Follistatin. This effect is also observed in adult human islets. Glucagon gene expression is inhibited at the transcriptional level by the Smad signaling pathway through the G3 DNA control element. Furthermore, Activin A decreases cell proliferation of InR1G9 and TC1 cells as well as cyclin D2 and arx gene expression, whose protein product Arx has been shown to be critical for -cell differentiation. Overexpression of Arx in Activin A-treated InR1G9 cells does not prevent the decrease in glucagon gene expression but corrects the inhibition of cell proliferation, indicating that Arx mediates the Activin A effects on the cell cycle. We conclude that Activin A has opposite effects on -cells compared with ß-cells, a finding that may have relevance during pancreatic endocrine lineage specification and physiological function of the adult islets.

This article has been cited by other articles:

				J. Gromada, I. Franklin, and C. B. Wollheim {alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains Endocr. Rev., February 1, 2007; 28(1): 84 - 116. [Abstract] [Full Text] [PDF]